{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:52:23Z","timestamp":1792601543241,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-07529-7","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:10:35Z","timestamp":1737396635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Human epididymis protein 4-annexin II binding promotes aberrant epithelial-fibroblast crosstalk in pulmonary fibrosis"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3522-9644","authenticated-orcid":false,"given":"Weishuai","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5255-920X","authenticated-orcid":false,"given":"Menglin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4519-6644","authenticated-orcid":false,"given":"Xingxing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhui","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5384-1418","authenticated-orcid":false,"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7387-496X","authenticated-orcid":false,"given":"Zhenshun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"7529_CR1","doi-asserted-by":"publisher","first-page":"2200957","DOI":"10.1183\/13993003.00957-2022","volume":"61","author":"AJ Podolanczuk","year":"2023","unstructured":"Podolanczuk, A. J. et al. Idiopathic pulmonary fibrosis: state of the art for 2023. Eur. Respir. J. 61, 2200957 (2023).","journal-title":"Eur. Respir. J."},{"key":"7529_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.74","volume":"3","author":"FJ Martinez","year":"2017","unstructured":"Martinez, F. J. et al. Idiopathic pulmonary fibrosis. Nat. Rev. Dis. Prim. 3, 17074 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"7529_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","volume":"17","author":"BJ Moss","year":"2022","unstructured":"Moss, B. J., Ryter, S. W. & Rosas, I. O. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annu. Rev. Pathol. 17, 515\u2013546 (2022).","journal-title":"Annu. Rev. Pathol."},{"key":"7529_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fphar.2013.00173","volume":"4","author":"A Camelo","year":"2014","unstructured":"Camelo, A., Dunmore, R., Sleeman, M. A. & Clarke, D. L. The epithelium in idiopathic pulmonary fibrosis: breaking the barrier. Front. Pharm. 4, 173 (2014).","journal-title":"Front. Pharm."},{"key":"7529_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1470-2045(06)70579-4","volume":"7","author":"D Bouchard","year":"2006","unstructured":"Bouchard, D. et al. Proteins with whey-acidic-protein motifs and cancer. Lancet Oncol. 7, 167\u2013174 (2006).","journal-title":"Lancet Oncol."},{"key":"7529_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/modpathol.3800612","volume":"19","author":"MT Galgano","year":"2006","unstructured":"Galgano, M. T., Hampton, G. M. & Frierson, H. F. Jr. Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod. Pathol. 19, 847\u2013853 (2006).","journal-title":"Mod. Pathol."},{"key":"7529_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nm.2989","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu, V. S. et al. Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat. Med. 19, 227\u2013231 (2013).","journal-title":"Nat. Med."},{"key":"7529_CR8","doi-asserted-by":"publisher","unstructured":"Yamamoto, M. et al. HE4 predicts progressive fibrosis and cardiovascular events in patients with dilated cardiomyopathy. J. Am. Heart Assoc. 10. https:\/\/doi.org\/10.1161\/JAHA.120.021069. (2021)","DOI":"10.1161\/JAHA.120.021069"},{"key":"7529_CR9","doi-asserted-by":"publisher","first-page":"992","DOI":"10.21037\/atm-22-4042","volume":"10","author":"M Tian","year":"2022","unstructured":"Tian, M. et al. Elevated serum human epididymis protein 4 is associated with disease severity and worse survival in idiopathic pulmonary fibrosis: a cohort study. Ann. Transl. Med. 10, 992 (2022).","journal-title":"Ann. Transl. Med."},{"key":"7529_CR10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.chest.2018.08.1083","volume":"154","author":"G Raghu","year":"2018","unstructured":"Raghu, G. et al. Idiopathic pulmonary fibrosis: prospective, case-controlled study of natural history and circulating biomarkers. Chest 154, 1359\u20131370 (2018).","journal-title":"Chest"},{"key":"7529_CR11","doi-asserted-by":"publisher","unstructured":"Zhang, M. et al. Increased levels of HE4 (WFDC2) in systemic sclerosis: a novel biomarker reflecting interstitial lung disease severity? Ther. Adv. Chronic Dis. 11, 2040622320956420. https:\/\/doi.org\/10.1177\/2040622320956420. (2020)","DOI":"10.1177\/2040622320956420"},{"key":"7529_CR12","first-page":"2167","volume":"40","author":"T Lin","year":"2022","unstructured":"Lin, T. et al. Human epididymis protein 4 as a new diagnostic biomarker for rheumatoid arthritis-associated interstitial lung disease. Clin. Exp. Rheumatol. 40, 2167\u20132174 (2022).","journal-title":"Clin. Exp. Rheumatol."},{"key":"7529_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.755268","volume":"8","author":"L Liang","year":"2021","unstructured":"Liang, L. et al. Serum human epididymis protein 4 as a novel biomarker in identifying patients with interstitial lung disease in rheumatoid arthritis. Front. Med. 8, 755268 (2021).","journal-title":"Front. Med."},{"key":"7529_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109609","volume":"115","author":"F Sun","year":"2023","unstructured":"Sun, F. et al. Human epididymis protein 4 as a clinical biomarker in identifying interstitial lung disease in patients with idiopathic inflammatory myopathies. Int. Immunopharmacol. 115, 109609 (2023).","journal-title":"Int. Immunopharmacol."},{"key":"7529_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1165\/rcmb.2013-0310OC","volume":"52","author":"Y Bauer","year":"2015","unstructured":"Bauer, Y. et al. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 52, 217\u2013231 (2015).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"7529_CR16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s13258-019-00836-4","volume":"41","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. Human epididymis protein 4 (HE4) protects against cystic pulmonary fibrosis associated-inflammation through inhibition of NF-\u03baB and MAPK singnaling. Genes Genomics 41, 1045\u20131053 (2019).","journal-title":"Genes Genomics"},{"key":"7529_CR17","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1096\/fj.201901950R","volume":"34","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Hypoxia-induced HE4 in tubular epithelial cells promotes extracellular matrix accumulation and renal fibrosis via NF-kappa B. FASEB J. 34, 2554\u20132567 (2020).","journal-title":"FASEB J."},{"key":"7529_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13046-020-01770-0","volume":"39","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15. J. Exp. Clin. Cancer Res. 39, 264 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"7529_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.797292","volume":"12","author":"Q Mei","year":"2022","unstructured":"Mei, Q., Liu, Z., Zuo, H., Yang, Z. & Qu, J. Idiopathic pulmonary fibrosis: an update on pathogenesis. Front. Pharm. 12, 797292 (2022).","journal-title":"Front. Pharm."},{"key":"7529_CR20","doi-asserted-by":"publisher","first-page":"L772","DOI":"10.1152\/ajplung.00553.2016","volume":"312","author":"M Schuliga","year":"2017","unstructured":"Schuliga, M. et al. Annexin A2 contributes to lung injury and fibrosis by augmenting factor Xa fibrogenic activity. Am. J. Physiol. Lung Cell Mol. Physiol. 312, L772\u2013L782 (2017).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"7529_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12931-022-02040-7","volume":"23","author":"Y Zhan","year":"2022","unstructured":"Zhan, Y. et al. Human epididymis protein 4 aggravates airway inflammation and remodeling in chronic obstructive pulmonary disease. Respir. Res. 23, 120 (2022).","journal-title":"Respir. Res."},{"key":"7529_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.path.2023.11.007","volume":"17","author":"MB Beasley","year":"2024","unstructured":"Beasley, M. B. Interstitial lung abnormalities. Surg. Pathol. Clin. 17, 215\u2013225 (2024).","journal-title":"Surg. Pathol. Clin."},{"key":"7529_CR23","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1164\/rccm.201708-1679LE","volume":"197","author":"ER Miller","year":"2018","unstructured":"Miller, E. R. et al. Histopathology of interstitial lung abnormalities in the context of lung nodule resections. Am. J. Respir. Crit. Care Med. 197, 955\u2013958 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"7529_CR24","first-page":"63","volume":"210","author":"GW Dougherty","year":"2024","unstructured":"Dougherty, G. W. et al. Recessively inherited deficiency of secreted WFDC2 (HE4) causes nasal polyposis and bronchiectasis. Am. J. Respir. Crit. Care Med. 210, 63\u201376 (2024).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"7529_CR25","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","volume":"392","author":"PA Flume","year":"2018","unstructured":"Flume, P. A., Chalmers, J. D. & Olivier, K. N. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet 392, 880\u2013890 (2018).","journal-title":"Lancet"},{"key":"7529_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1164\/rccm.201306-1141WS","volume":"189","author":"TS Blackwell","year":"2014","unstructured":"Blackwell, T. S. et al. Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am. J. Respir. Crit. Care Med. 189, 214\u2013222 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"7529_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.amjms.2019.01.010","volume":"357","author":"NI Winters","year":"2019","unstructured":"Winters, N. I., Burman, A., Kropski, J. A. & Blackwell, T. S. Epithelial injury and dysfunction in the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Med. Sci. 357, 374\u2013378 (2019).","journal-title":"Am. J. Med. Sci."},{"key":"7529_CR28","doi-asserted-by":"publisher","first-page":"20833","DOI":"10.1074\/jbc.M412653200","volume":"280","author":"A Semov","year":"2005","unstructured":"Semov, A. et al. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J. Biol. Chem. 280, 20833\u201320841 (2005).","journal-title":"J. Biol. Chem."},{"key":"7529_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/406273","volume":"2012","author":"N Hedhli","year":"2012","unstructured":"Hedhli, N. et al. The annexin A2\/S100A10 system in health and disease: emerging paradigms. J. Biomed. Biotechnol. 2012, 406273 (2012).","journal-title":"J. Biomed. Biotechnol."},{"key":"7529_CR30","first-page":"4702","volume":"59","author":"K Bj\u00f8rnland","year":"1999","unstructured":"Bj\u00f8rnland, K. et al. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res. 59, 4702\u20134708 (1999).","journal-title":"Cancer Res."},{"key":"7529_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/15548627.2017.1409405","volume":"14","author":"K Wang","year":"2018","unstructured":"Wang, K. et al. Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux. Autophagy 14, 269\u2013282 (2018).","journal-title":"Autophagy"},{"key":"7529_CR32","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1042\/CS20180687","volume":"133","author":"Y Lei","year":"2019","unstructured":"Lei, Y. et al. Cell-surface translocation of annexin A2 contributes to bleomycin-induced pulmonary fibrosis by mediating inflammatory response in mice. Clin. Sci. 133, 789\u2013804 (2019).","journal-title":"Clin. Sci."},{"key":"7529_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/BF01076592","volume":"149-150","author":"DM Waisman","year":"1995","unstructured":"Waisman, D. M. Annexin II tetramer: structure and function. Mol. Cell Biochem. 149-150, 301\u2013322 (1995).","journal-title":"Mol. Cell Biochem."},{"key":"7529_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nrm1661","volume":"6","author":"V Gerke","year":"2005","unstructured":"Gerke, V., Creutz, C. E. & Moss, S. E. Annexins: linking Ca2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6, 449\u2013461 (2005).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"7529_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1152\/physrev.00030.2001","volume":"82","author":"V Gerke","year":"2002","unstructured":"Gerke, V. & Moss, S. E. Annexins: from structure to function. Physiol. Rev. 82, 331\u2013371 (2002).","journal-title":"Physiol. Rev."},{"key":"7529_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0864-4","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. Interaction of HE4 and ANXA2 exists in various malignant cells-HE4-ANXA2-MMP2 protein complex promotes cell migration. Cancer Cell Int. 19, 161 (2019).","journal-title":"Cancer Cell Int."},{"key":"7529_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-243","volume":"13","author":"H Zhuang","year":"2014","unstructured":"Zhuang, H. et al. Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells. Mol. Cancer 13, 243 (2014).","journal-title":"Mol. Cancer"},{"key":"7529_CR38","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2012.02.008","volume":"419","author":"R Lu","year":"2012","unstructured":"Lu, R. et al. Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility. Biochem. Biophys. Res Commun. 419, 274\u2013280 (2012).","journal-title":"Biochem. Biophys. Res Commun."},{"key":"7529_CR39","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.4049\/jimmunol.179.5.3297","volume":"179","author":"Y Zhang","year":"2007","unstructured":"Zhang, Y., Zhou, Z. H., Bugge, T. H. & Wahl, L. M. Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin. J. Immunol. 179, 3297\u20133304 (2007).","journal-title":"J. Immunol."},{"key":"7529_CR40","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2353\/ajpath.2007.060850","volume":"170","author":"E Ortiz-Zapater","year":"2007","unstructured":"Ortiz-Zapater, E. et al. Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1\/2 activation through epidermal growth factor receptor and annexin A2. Am. J. Pathol. 170, 1573\u20131584 (2007).","journal-title":"Am. J. Pathol."},{"key":"7529_CR41","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.bbrc.2019.11.011","volume":"522","author":"T Zhang","year":"2020","unstructured":"Zhang, T. et al. WFDC2 gene deletion in mouse led to severe dyspnea and type-I alveolar cell apoptosis. Biochem. Biophys. Res Commun. 522, 456\u2013462 (2020).","journal-title":"Biochem. Biophys. Res Commun."},{"key":"7529_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65353-x","volume":"10","author":"NE James","year":"2020","unstructured":"James, N. E. et al. The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes. Sci. Rep. 10, 8558 (2020).","journal-title":"Sci. Rep."},{"key":"7529_CR43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fonc.2017.00332","volume":"7","author":"JR Ribeiro","year":"2018","unstructured":"Ribeiro, J. R. et al. Human epididymis protein 4 promotes events associated with metastatic ovarian cancer via regulation of the extracelluar matrix. Front Oncol. 7, 332 (2018).","journal-title":"Front Oncol."},{"key":"7529_CR44","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu, G. et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am. J. Respir. Crit. Care Med. 205, e18\u2013e47 (2022).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"7529_CR45","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jcp.41.4.467","volume":"41","author":"T Ashcroft","year":"1988","unstructured":"Ashcroft, T., Simpson, J. M. & Timbrell, V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41, 467\u2013470 (1988).","journal-title":"J. Clin. Pathol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07529-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07529-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07529-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:10:37Z","timestamp":1737396637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07529-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7529"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-07529-7","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}